Insulin detemir--a new basal insulin analog (Q36013053)

11 August 2017

1 reference

title

Insulin detemir--a new basal insulin analog (English)

1 reference

11 August 2017

1 reference

1 reference

Jennifer D Goldman-Levine

series ordinal

1

1 reference

PubMed ID

15657117

11 August 2017

Karen W Lee

series ordinal

2

1 reference

PubMed ID

15657117

11 August 2017

language of work or name

English

0 references

publication date

18 January 2005

1 reference

Annals of Pharmacotherapy

11 August 2017

1 reference

11 August 2017

39

1 reference

11 August 2017

3

1 reference

11 August 2017

502-507

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

11 August 2017

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

Clinical pharmacology of human insulin

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

21 January 2018

1 reference

Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo

21 January 2018

1 reference

Rapid and long-acting analogues as an approach to improve insulin therapy: an evidence-based medicine assessment

21 January 2018

1 reference

Insulins today and beyond

21 January 2018

1 reference

Mechanism of protracted metabolic effects of fatty acid acylated insulin, NN304, in dogs: retention of NN304 by albumin

21 January 2018

1 reference

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

21 January 2018

1 reference

Insulin Detemir Is Characterized by a Consistent Pharmacokinetic Profile Across Age-Groups in Children, Adolescents, and Adults With Type 1 Diabetes

21 January 2018

1 reference

Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.

21 January 2018

1 reference

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

21 January 2018

1 reference

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

21 January 2018

1 reference

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E334

1 reference

11 August 2017

1 reference

PubMed ID

15657117